SV Investments

SV has invested in 91 companies and its latest investment was Imbria Pharmaceuticals on Apr 09, 2025

COMPANY

DESCRIPTION

AMOUNT

INVESTMENT DATE

ROUND

EXIT DATE

$57.5M
Apr 09, 2025
-
Perfuze is an Ireland-based medical device company that develops and markets catheter-based diagnostic systems for clot removal applications in stroke patients.
$24M
Mar 12, 2025
-
$20M
Mar 12, 2025
-
Ria Health is a California-based telehealth platform that offers alcohol use disorder treatment programs for individuals.
-
Mar 05, 2025
-
AdvanCell is an Australia-based radiopharmaceutical company that develops and commercializes novel therapeutics for the treatment of cancer.
$112M
Feb 02, 2025
-

Frequently Asked Questions about SV

  1. What is SV investing in?

    SV has invested in 91 companies including Imbria Pharmaceuticals, Perfuze and Montara Therapeutics
  2. What company did SV invest in?

    SV invested in a total 91 companies including Imbria Pharmaceuticals, Perfuze and Montara Therapeutics
  1. What are the top 5 investments by SV?

    The top companies in which SV invested are Imbria Pharmaceuticals, Perfuze, Montara Therapeutics, Ria Health and AdvanCell